title: Improved long-term survival in multiple myeloma up to the age of 80 years.
authors.affiliation: 1] Division of Hematology, Department of Medicine, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden [2] Faculty of Medicine, University of Iceland and Department of Hematology, Landspitali National University Hospital, Reykjavik, Iceland.
authors.forename: S Y
authors.initials: SY
authors.lastname: Kristinsson
authors.affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
authors.forename: W F
authors.initials: WF
authors.lastname: Anderson
authors.affiliation: Multiple Myeloma Section, Metabolism Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
authors.forename: O
authors.initials: O
authors.lastname: Landgren
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis / Q000401:mortality* / Q000628:therapy; D011379:Prognosis; D018426:SEER Program; D015996:Survival Rate; D013997:Time Factors; D055815:Young Adult